Virtual Seminars (On-Demand)
| Seminar Title:
Nivolumab+ipilimumab for first-line treatment of malignant pleural mesothelioma |
Sponsored by:
|
| Seminar Title:
Topic: Developments in Compensation for Mesothelioma: Immunotherapy and Home Renovation Cases |
Sponsored by:
|
-
The International Mesothelioma Interest Group (iMig) is an independent international group of scientists and clinicians working to understand, cure and prevent mesothelioma. -
CONFERENCE SECRETARIAT
International Conference Services
300-1201 West Pender Street, Vancouver, B.C, Canada V6E 2V2 Tel. [+1] 604-681-2153
Email: iMig2021 at icsevents.com
Web: www.icsevents.com
